Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC

The myelocytomatosis oncogene (MYC) is an important driver in a subtype of pancreatic ductal adenocarcinoma (PDAC). However, MYC remains a challenging therapeutic target; therefore, identifying druggable synthetic lethal interactions in MYC‐active PDAC may lead to novel precise therapies. First, to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Oncol
Asıl Yazarlar: Lankes, Katharina, Hassan, Zonera, Doffo, María Josefina, Schneeweis, Christian, Lier, Svenja, Öllinger, Rupert, Rad, Roland, Krämer, Oliver H., Keller, Ulrich, Saur, Dieter, Reichert, Maximilian, Schneider, Günter, Wirth, Matthias
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7718946/
https://ncbi.nlm.nih.gov/pubmed/33099868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12835
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller